Clinical Trial Update: A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark

View source ↗

Summary

This notice describes a clinical study evaluating GP73 as a tumor marker for hepatocellular carcinoma, conducted at Peking Union Medical College Hospital, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN